89 related articles for article (PubMed ID: 27298001)
1. Development of novel NK3 receptor antagonists with reduced environmental impact.
Yamamoto K; Okazaki S; Ohno H; Matsuda F; Ohkura S; Maeda K; Fujii N; Oishi S
Bioorg Med Chem; 2016 Aug; 24(16):3494-500. PubMed ID: 27298001
[TBL] [Abstract][Full Text] [Related]
2. Neurokinin B signaling in the female rat: a novel link between stress and reproduction.
Grachev P; Li XF; Hu MH; Li SY; Millar RP; Lightman SL; O'Byrne KT
Endocrinology; 2014 Jul; 155(7):2589-601. PubMed ID: 24708241
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo characterization of the non-peptide NK3 receptor antagonist SB-223412 (talnetant): potential therapeutic utility in the treatment of schizophrenia.
Dawson LA; Cato KJ; Scott C; Watson JM; Wood MD; Foxton R; de la Flor R; Jones GA; Kew JN; Cluderay JE; Southam E; Murkitt GS; Gartlon J; Pemberton DJ; Jones DN; Davies CH; Hagan J
Neuropsychopharmacology; 2008 Jun; 33(7):1642-52. PubMed ID: 17728699
[TBL] [Abstract][Full Text] [Related]
4. Scaffold hopping of fused piperidine-type NK3 receptor antagonists to reduce environmental impact.
Yamamoto K; Inuki S; Ohno H; Oishi S
Bioorg Med Chem; 2019 May; 27(10):2019-2026. PubMed ID: 30975505
[TBL] [Abstract][Full Text] [Related]
5. Morphologic evidence that neurokinin B modulates gonadotropin-releasing hormone secretion via neurokinin 3 receptors in the rat median eminence.
Krajewski SJ; Anderson MJ; Iles-Shih L; Chen KJ; Urbanski HF; Rance NE
J Comp Neurol; 2005 Aug; 489(3):372-86. PubMed ID: 16025449
[TBL] [Abstract][Full Text] [Related]
6. Neuropeptide derivatives to regulate the reproductive axis: Kisspeptin receptor (KISS1R) ligands and neurokinin-3 receptor (NK3R) ligands.
Oishi S; Fujii N
Biopolymers; 2016 Nov; 106(4):588-97. PubMed ID: 27271543
[TBL] [Abstract][Full Text] [Related]
7. Development of novel neurokinin 3 receptor (NK3R) selective agonists with resistance to proteolytic degradation.
Misu R; Oishi S; Yamada A; Yamamura T; Matsuda F; Yamamoto K; Noguchi T; Ohno H; Okamura H; Ohkura S; Fujii N
J Med Chem; 2014 Oct; 57(20):8646-51. PubMed ID: 25247671
[TBL] [Abstract][Full Text] [Related]
8. Neurokinin-3 receptor-specific antagonists talnetant and osanetant show distinct mode of action in cellular Ca2+ mobilization but display similar binding kinetics and identical mechanism of binding in ligand cross-competition.
Tian G; Wilkins D; Scott CW
Mol Pharmacol; 2007 Mar; 71(3):902-11. PubMed ID: 17172464
[TBL] [Abstract][Full Text] [Related]
9. Prenatal testosterone excess decreases neurokinin 3 receptor immunoreactivity within the arcuate nucleus KNDy cell population.
Ahn T; Fergani C; Coolen LM; Padmanabhan V; Lehman MN
J Neuroendocrinol; 2015 Feb; 27(2):100-10. PubMed ID: 25496429
[TBL] [Abstract][Full Text] [Related]
10. The neurokinin-3 receptor (NK3R) antagonist SB222200 prevents the apomorphine-evoked surface but not nuclear NK3R redistribution in dopaminergic neurons of the rat ventral tegmental area.
Hether S; Misono K; Lessard A
Neuroscience; 2013 Sep; 247():12-24. PubMed ID: 23673279
[TBL] [Abstract][Full Text] [Related]
11. Differentially regulated expression of neurokinin B (NKB)/NK3 receptor system in uterine leiomyomata.
Cañete H; Dorta I; Hernández M; Cejudo Roman A; Candenas L; Pinto FM; Valladares F; Báez D; Montes de Oca F; Bello AR; Almeida TA
Hum Reprod; 2013 Jul; 28(7):1799-808. PubMed ID: 23656837
[TBL] [Abstract][Full Text] [Related]
12. Expression of neurokinin B/NK3 receptor and kisspeptin/KISS1 receptor in human granulosa cells.
García-Ortega J; Pinto FM; Fernández-Sánchez M; Prados N; Cejudo-Román A; Almeida TA; Hernández M; Romero M; Tena-Sempere M; Candenas L
Hum Reprod; 2014 Dec; 29(12):2736-46. PubMed ID: 25316443
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationship study of tachykinin peptides for the development of novel neurokinin-3 receptor selective agonists.
Misu R; Noguchi T; Ohno H; Oishi S; Fujii N
Bioorg Med Chem; 2013 Apr; 21(8):2413-2417. PubMed ID: 23473945
[TBL] [Abstract][Full Text] [Related]
14. Evidence that Neurokinin B Controls Basal Gonadotropin-Releasing Hormone Secretion but Is Not Critical for Estrogen-Positive Feedback in Sheep.
Li Q; Millar RP; Clarke IJ; Smith JT
Neuroendocrinology; 2015; 101(2):161-74. PubMed ID: 25677216
[TBL] [Abstract][Full Text] [Related]
15. Suppression of the GnRH pulse generator by neurokinin B involves a κ-opioid receptor-dependent mechanism.
Grachev P; Li XF; Kinsey-Jones JS; di Domenico AL; Millar RP; Lightman SL; O'Byrne KT
Endocrinology; 2012 Oct; 153(10):4894-904. PubMed ID: 22903614
[TBL] [Abstract][Full Text] [Related]
16. Effects of intravenous administration of neurokinin receptor subtype-selective agonists on gonadotropin-releasing hormone pulse generator activity and luteinizing hormone secretion in goats.
Yamamura T; Wakabayashi Y; Ohkura S; Navarro VM; Okamura H
J Reprod Dev; 2015; 61(1):20-9. PubMed ID: 25345909
[TBL] [Abstract][Full Text] [Related]
17. Neurokinin B receptor antagonism decreases luteinising hormone pulse frequency and amplitude and delays puberty onset in the female rat.
Li SY; Li XF; Hu MH; Shao B; Poston L; Lightman SL; O'Byrne KT
J Neuroendocrinol; 2014 Aug; 26(8):521-7. PubMed ID: 24863620
[TBL] [Abstract][Full Text] [Related]
18. TACR3 mutations disrupt NK3R function through distinct mechanisms in GnRH-deficient patients.
Noel SD; Abreu AP; Xu S; Muyide T; Gianetti E; Tusset C; Carroll J; Latronico AC; Seminara SB; Carroll RS; Kaiser UB
FASEB J; 2014 Apr; 28(4):1924-37. PubMed ID: 24376026
[TBL] [Abstract][Full Text] [Related]
19. Augmentation of antipsychotic-induced neurochemical changes by the NK3 receptor antagonist talnetant (SB-223412).
de la Flor R; Dawson LA
Neuropharmacology; 2009 Feb; 56(2):342-9. PubMed ID: 18822303
[TBL] [Abstract][Full Text] [Related]
20. Me-talnetant and osanetant interact within overlapping but not identical binding pockets in the human tachykinin neurokinin 3 receptor transmembrane domains.
Malherbe P; Bissantz C; Marcuz A; Kratzeisen C; Zenner MT; Wettstein JG; Ratni H; Riemer C; Spooren W
Mol Pharmacol; 2008 Jun; 73(6):1736-50. PubMed ID: 18308898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
